CME Group (CME) PT Lowered to $270 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts CME Hot Sheet
Price: $304.06 --0%
Rating Summary:
14 Buy, 11 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 7
Rating Summary:
14 Buy, 11 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 7
Join SI Premium – FREE
Barclays analyst Benjamin Budish lowered the price target on CME Group (NASDAQ: CME) to $270.00 (from $316.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- CME Group posts record October ADV of 30M contracts, up 15%
- CME Group Reports Record October ADV of 30 Million Contracts, up 15% Year Over Year
- AMD (AMD) PT Lowered to $650 at Wells Fargo
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
